Biogen to buy Apellis Pharmaceuticals

Biogen to buy Apellis Pharmaceuticals

Signage outside the Biogen Inc. office in the Kendall Square neighborhood of Cambridge, Massachusetts, US, on Tuesday, Sept. 6, 2022.  Adam Glanzman | Bloomberg | Getty Images Biogen has agreed to acquire ​Apellis ​Pharmaceuticals for about $5.6 ⁠billion in cash, expanding its portfolio of rare-disease medicines, the companies ​said on ​Tuesday. The deal ​marks Biogen’s…

Read More
Bristol Myers Squibb turns to China’s Hengrui to replenish pipeline

Bristol Myers Squibb turns to China’s Hengrui to replenish pipeline

One of America’s largest pharmaceutical companies this week said it will partner with a Chinese drugmaker to test some of its experimental drugs and discover new ones, a deal that could mark the next phase of coordination across continents. Bristol Myers Squibb on Tuesday announced the potential multi-billion dollar partnership with one of China’s top…

Read More